Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds.

Singh K, Gallazzi F, Hill KJ, Burke DH, Lange MJ, Quinn TP, Neogi U, Sönnerborg A.

Front Microbiol. 2019 Jun 20;10:1227. doi: 10.3389/fmicb.2019.01227. eCollection 2019.

2.

Somatostatin receptor targeting with hydrophilic [99mTc/186Re]Tc/Re-tricarbonyl NODAGA and NOTA complexes.

Makris G, Kuchuk M, Gallazzi F, Jurisson SS, Smith CJ, Hennkens HM.

Nucl Med Biol. 2019 Apr;71:39-46. doi: 10.1016/j.nucmedbio.2019.04.004. Epub 2019 Apr 30.

PMID:
31129499
3.

Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors.

Lever JR, Fergason-Cantrell EA, Carmack TL, Watkinson LD, Gallazzi F.

Nucl Med Biol. 2019 Mar;70:53-66. doi: 10.1016/j.nucmedbio.2019.02.001. Epub 2019 Mar 7.

PMID:
30933866
4.

Synthesis and evaluation of Re/99mTc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent.

Radford LL, Papagiannopoulou D, Gallazzi F, Berendzen A, Watkinson L, Carmack T, Lewis MR, Jurisson SS, Hennkens HM.

Bioorg Med Chem. 2019 Feb 1;27(3):492-501. doi: 10.1016/j.bmc.2018.12.028. Epub 2018 Dec 21.

PMID:
30594453
5.

NOTA and NODAGA [99mTc]Tc- and [186Re]Re-Tricarbonyl Complexes: Radiochemistry and First Example of a [99mTc]Tc-NODAGA Somatostatin Receptor-Targeting Bioconjugate.

Makris G, Radford LL, Kuchuk M, Gallazzi F, Jurisson SS, Smith CJ, Hennkens HM.

Bioconjug Chem. 2018 Dec 19;29(12):4040-4049. doi: 10.1021/acs.bioconjchem.8b00670. Epub 2018 Nov 26.

PMID:
30412382
6.

Correction to Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.

Chen F, Zhang X, Ma K, Madajewski B, Benezra M, Zhang L, Phillips E, Turker MZ, Gallazzi F, Penate-Medina O, Overholtzer M, Pauliah M, Gonen M, Zanzonico P, Wiesner U, Bradbury MS, Quinn TP.

ACS Appl Mater Interfaces. 2018 Oct 24;10(42):36584. doi: 10.1021/acsami.8b16671. Epub 2018 Oct 11. No abstract available.

PMID:
30360123
7.

Aptamer-displaying peptide amphiphile micelles as a cell-targeted delivery vehicle of peptide cargoes.

Smith JD, Cardwell LN, Porciani D, Nguyen JA, Zhang R, Gallazzi F, Tata RR, Burke DH, Daniels MA, Ulery BD.

Phys Biol. 2018 Oct 22;15(6):065006. doi: 10.1088/1478-3975/aadb68.

PMID:
30124431
8.

Synthesis of hydrophilic HYNIC-[1,2,4,5]tetrazine conjugates and their use in antibody pretargeting with 99mTc.

García MF, Gallazzi F, Junqueira MS, Fernández M, Camacho X, Mororó JDS, Faria D, Carneiro CG, Couto M, Carrión F, Pritsch O, Chammas R, Quinn T, Cabral P, Cerecetto H.

Org Biomol Chem. 2018 Jul 25;16(29):5275-5285. doi: 10.1039/c8ob01255e.

PMID:
29974915
9.

Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.

Zhang R, Kramer JS, Smith JD, Allen BN, Leeper CN, Li X, Morton LD, Gallazzi F, Ulery BD.

AAPS J. 2018 Jun 1;20(4):73. doi: 10.1208/s12248-018-0233-6.

PMID:
29858738
10.

A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability.

Feng Y, DeGraffenreid AJ, Phipps MD, Rold TL, Okoye NC, Gallazzi FA, Barnes CL, Cutler CS, Ketring AR, Hoffman TJ, Jurisson SS.

Nucl Med Biol. 2018 Jun;61:1-10. doi: 10.1016/j.nucmedbio.2018.03.001. Epub 2018 Mar 10.

PMID:
29571038
11.

Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.

Chen F, Zhang X, Ma K, Madajewski B, Benezra M, Zhang L, Phillips E, Turker MZ, Gallazzi F, Penate-Medina O, Overholtzer M, Pauliah M, Gonen M, Zanzonico P, Wiesner U, Bradbury MS, Quinn TP.

ACS Appl Mater Interfaces. 2018 Feb 7;10(5):4379-4393. doi: 10.1021/acsami.7b14362. Epub 2018 Jan 24. Erratum in: ACS Appl Mater Interfaces. 2018 Oct 24;10(42):36584.

12.

Open-Cavity Spun Fiber Raman Lasers with Dual Polarization Output.

Nuño J, Rizzelli G, Gallazzi F, Prieto F, Pulido C, Corredera P, Wabnitz S, Ania-Castanon JD.

Sci Rep. 2017 Oct 20;7(1):13681. doi: 10.1038/s41598-017-13193-7.

13.

Performance optimization in ultra-long Raman laser amplified 10×30 GBaud DP-QPSK transmission: balancing RIN and ASE noise.

Gallazzi F, Rizzelli G, Iqbal MA, Tan M, Harper P, Ania-Castañón JD.

Opt Express. 2017 Sep 4;25(18):21454-21459. doi: 10.1364/OE.25.021454.

PMID:
29041442
14.

Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment.

Feng Y, Phelps TE, Carroll V, Gallazzi F, Sieckman G, Hoffman TJ, Barnes CL, Ketring AR, Hennkens HM, Jurisson SS.

Dalton Trans. 2017 Oct 31;46(42):14677-14690. doi: 10.1039/c7dt02407j.

PMID:
28951905
15.

Single-Molecule Peptide-Lipid Affinity Assay Reveals Interplay between Solution Structure and Partitioning.

Matin TR, Sigdel KP, Utjesanovic M, Marsh BP, Gallazzi F, Smith VF, Kosztin I, King GM.

Langmuir. 2017 Apr 25;33(16):4057-4065. doi: 10.1021/acs.langmuir.7b00100. Epub 2017 Apr 11.

PMID:
28343391
16.

Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors.

Radford L, Gallazzi F, Watkinson L, Carmack T, Berendzen A, Lewis MR, Jurisson SS, Papagiannopoulou D, Hennkens HM.

Nucl Med Biol. 2017 Apr;47:4-9. doi: 10.1016/j.nucmedbio.2016.12.002. Epub 2016 Dec 9.

PMID:
28043006
17.

Impact of input FBG reflectivity and forward pump power on RIN transfer in ultralong Raman laser amplifiers.

Rizzelli G, Iqbal MA, Gallazzi F, Rosa P, Tan M, Ania-Castañón JD, Krzczanowicz L, Corredera P, Phillips I, Forysiak W, Harper P.

Opt Express. 2016 Dec 12;24(25):29170-29175. doi: 10.1364/OE.24.029170.

PMID:
27958578
18.

The Effect of A Hexanoic Acid Linker Insertion on the Pharmacokinetics and Tumor Targeting Properties of the Melanoma Imaging Agent 99mTc-HYNIC-cycMSH.

Teixeira V, Fernández M, Oddone N, Zhang X, Gallazzi F, Cerecetto H, Gambini JP, Porcal W, Cabral P, Quinn TP.

Anticancer Agents Med Chem. 2017;17(8):1144-1152. doi: 10.2174/1871520616666161206144414.

PMID:
27924732
19.

Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation.

Demoin DW, Dame AN, Minard WD, Gallazzi F, Seickman GL, Rold TL, Bernskoetter N, Fassbender ME, Hoffman TJ, Deakyne CA, Jurisson SS.

Nucl Med Biol. 2016 Dec;43(12):802-811. doi: 10.1016/j.nucmedbio.2016.08.017. Epub 2016 Aug 31.

20.

Synthesis, Characterization, and In Vitro Evaluation of New (99m)Tc/Re(V)-Cyclized Octreotide Analogues: An Experimental and Computational Approach.

Li Y, Ma L, Gaddam V, Gallazzi F, Hennkens HM, Harmata M, Lewis MR, Deakyne CA, Jurisson SS.

Inorg Chem. 2016 Feb 1;55(3):1124-33. doi: 10.1021/acs.inorgchem.5b02306. Epub 2016 Jan 20.

PMID:
26789775
21.

Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.

Jia F, Balaji BS, Gallazzi F, Lewis MR.

Nucl Med Biol. 2015 Nov;42(11):809-15. doi: 10.1016/j.nucmedbio.2015.06.002. Epub 2015 Jun 9.

PMID:
26239085
22.

Generation of Reactive Oxygen Species Mediated by 1‑Hydroxyphenazine, a Virulence Factor of Pseudomonas aeruginosa.

Sinha S, Shen X, Gallazzi F, Li Q, Zmijewski JW, Lancaster JR Jr, Gates KS.

Chem Res Toxicol. 2015 Feb 16;28(2):175-81.

PMID:
25590513
23.

Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.

Kirby KA, Ong YT, Hachiya A, Laughlin TG, Chiang LA, Pan Y, Moran JL, Marchand B, Singh K, Gallazzi F, Quinn TP, Yoshimura K, Murakami T, Matsushita S, Sarafianos SG.

FASEB J. 2015 Jan;29(1):70-80. doi: 10.1096/fj.14-252262. Epub 2014 Oct 28.

24.

Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.

Garcia MF, Zhang X, Gallazzi F, Fernandez M, Moreno M, Gambini JP, Porcal W, Cabral P, Quinn TP.

Anticancer Agents Med Chem. 2015;15(1):122-30.

PMID:
25175799
25.

[99mTc(CO)3]+ and [99mTcO2]+ radiolabeled cyclic melanotropin peptides for melanoma SPECT imaging.

Zhang X, Teixeira V, Porcal W, Cabral P, Gambini JP, Fernandez M, Gallazzi F, Quinn TP.

Curr Radiopharm. 2014;7(1):63-74.

PMID:
25022516
26.

Isotopic labeling experiments that elucidate the mechanism of DNA strand cleavage by the hypoxia-selective antitumor agent 1,2,4-benzotriazine 1,4-di-N-oxide.

Shen X, Rajapakse A, Gallazzi F, Junnotula V, Fuchs-Knotts T, Glaser R, Gates KS.

Chem Res Toxicol. 2014 Jan 21;27(1):111-8. doi: 10.1021/tx400356y. Epub 2013 Dec 19.

27.

Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging.

Guo H, Gallazzi F, Miao Y.

Mol Pharm. 2013 Apr 1;10(4):1400-8. doi: 10.1021/mp3006984. Epub 2013 Mar 1.

28.

Copper-62 labeled ReCCMSH peptide analogs for melanoma PET imaging.

Zhang X, Yue Z, Lu BY, Vazquez-Flores GJ, Yuen J, Figueroa SD, Gallazzi F, Cutler C, Quinn TP, Lacy JL.

Curr Radiopharm. 2012 Oct;5(4):329-35.

PMID:
22724422
29.

Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.

Guo H, Gallazzi F, Miao Y.

Bioconjug Chem. 2012 Jun 20;23(6):1341-8. doi: 10.1021/bc300191z. Epub 2012 Jun 5.

30.

(64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.

Kumar SR, Gallazzi FA, Quinn TP, Deutscher SL.

J Nucl Med. 2011 Nov;52(11):1819-26. doi: 10.2967/jnumed.111.093716. Epub 2011 Oct 7.

31.

Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation.

McDonough RT, Paranjape G, Gallazzi F, Nichols MR.

Arch Biochem Biophys. 2011 Oct;514(1-2):27-32. doi: 10.1016/j.abb.2011.07.018. Epub 2011 Aug 6.

PMID:
21843498
32.

A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging.

Guo H, Gallazzi F, Sklar LA, Miao Y.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5184-7. doi: 10.1016/j.bmcl.2011.07.055. Epub 2011 Jul 23.

33.

Effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-MSH peptides.

Guo H, Yang J, Gallazzi F, Miao Y.

J Nucl Med. 2011 Apr;52(4):608-16. doi: 10.2967/jnumed.110.086009. Epub 2011 Mar 18.

34.

In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.

Kumar SR, Gallazzi FA, Ferdani R, Anderson CJ, Quinn TP, Deutscher SL.

Cancer Biother Radiopharm. 2010 Dec;25(6):693-703. doi: 10.1089/cbr.2010.0820.

35.

In vitro structure-activity relationship of Re-cyclized octreotide analogues.

Dannoon SF, Bigott-Hennkens HM, Ma L, Gallazzi F, Lewis MR, Jurisson SS.

Nucl Med Biol. 2010 Jul;37(5):527-37. doi: 10.1016/j.nucmedbio.2010.03.008.

36.

Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.

Guo H, Yang J, Gallazzi F, Miao Y.

J Nucl Med. 2010 Mar;51(3):418-26. doi: 10.2967/jnumed.109.071787. Epub 2010 Feb 11.

37.

Probing the amyloid-beta(1-40) fibril environment with substituted tryptophan residues.

Touchette JC, Williams LL, Ajit D, Gallazzi F, Nichols MR.

Arch Biochem Biophys. 2010 Feb 15;494(2):192-7. doi: 10.1016/j.abb.2009.12.007. Epub 2009 Dec 6.

PMID:
19995549
38.

Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.

Guo H, Yang J, Gallazzi F, Prossnitz ER, Sklar LA, Miao Y.

Bioconjug Chem. 2009 Nov;20(11):2162-8. doi: 10.1021/bc9003475.

39.

Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.

Yang J, Guo H, Gallazzi F, Berwick M, Padilla RS, Miao Y.

Bioconjug Chem. 2009 Aug 19;20(8):1634-42. doi: 10.1021/bc9001954. Epub 2009 Jun 24.

40.

Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.

Wei L, Zhang X, Gallazzi F, Miao Y, Jin X, Brechbiel MW, Xu H, Clifford T, Welch MJ, Lewis JS, Quinn TP.

Nucl Med Biol. 2009 May;36(4):345-54. doi: 10.1016/j.nucmedbio.2009.01.007. Epub 2009 Mar 26.

41.

Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector.

Abd-Elgaliel WR, Gallazzi F, Garrison JC, Rold TL, Sieckman GL, Figueroa SD, Hoffman TJ, Lever SZ.

Bioconjug Chem. 2008 Oct;19(10):2040-8. doi: 10.1021/bc800290c. Epub 2008 Sep 23.

42.

Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates.

Jia F, Figueroa SD, Gallazzi F, Balaji BS, Hannink M, Lever SZ, Hoffman TJ, Lewis MR.

J Nucl Med. 2008 Mar;49(3):430-8. doi: 10.2967/jnumed.107.045138. Epub 2008 Feb 20.

43.

Synthesis and in vitro evaluation of a rhenium-cyclized somatostatin derivative series.

Bigott-Hennkens HM, Junnotula S, Ma L, Gallazzi F, Lewis MR, Jurisson SS.

J Med Chem. 2008 Mar 13;51(5):1223-30. doi: 10.1021/jm701056x. Epub 2008 Feb 13.

PMID:
18269231
44.

111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.

Miao Y, Gallazzi F, Guo H, Quinn TP.

Bioconjug Chem. 2008 Feb;19(2):539-47. doi: 10.1021/bc700317w. Epub 2008 Jan 16.

45.

Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

Wei L, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Vāvere AL, Lewis JS.

Nucl Med Biol. 2007 Nov;34(8):945-53. Epub 2007 Sep 4.

46.

Total solid-phase synthesis of bombesin analogs with different functional groups at the C-terminus.

Abd-Elgaliel WR, Gallazzi F, Lever SZ.

J Pept Sci. 2007 Jul;13(7):487-92.

PMID:
17559059
47.

Phosphoprotein and phosphopeptide interactions with the FHA domain from Arabidopsis kinase-associated protein phosphatase.

Ding Z, Wang H, Liang X, Morris ER, Gallazzi F, Pandit S, Skolnick J, Walker JC, Van Doren SR.

Biochemistry. 2007 Mar 13;46(10):2684-96. Epub 2007 Feb 16.

PMID:
17302430
48.

Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.

Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS.

J Nucl Med. 2007 Jan;48(1):64-72.

49.

An efficient, convenient solid-phase synthesis of amino acid-modified peptide nucleic acid monomers and oligomers.

Balaji BS, Gallazzi F, Jia F, Lewis MR.

Bioconjug Chem. 2006 Mar-Apr;17(2):551-8.

PMID:
16536490
50.

PhosphoThr peptide binding globally rigidifies much of the FHA domain from Arabidopsis receptor kinase-associated protein phosphatase.

Ding Z, Lee GI, Liang X, Gallazzi F, Arunima A, Van Doren SR.

Biochemistry. 2005 Aug 2;44(30):10119-34.

Supplemental Content

Loading ...
Support Center